Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Calabretta

Showing results (171-180 of 187) with videos related to

Pageof 19
Sort By:
Blood|July 15, 1995
Phosphatidylinositol-3 kinase activity is regulated by BCR/ABL and is required for the growth of Philadelphia chromosome-positive cellsT Skorski, P Kanakaraj, M Nieborowska-Skorska, et al.
Cancer Research|November 1, 1994
p130/pRb2 has growth suppressive properties similar to yet distinctive from those of retinoblastoma family members pRb and p107P P Claudio, C M Howard, A Baldi, et al.
Leukemia|January 1, 1994
Antisense BCR-ABL oligonucleotides induce apoptosis in the Philadelphia chromosome-positive cell line BV173T F Smetsers, T Skorski, L T van de Locht, et al.
Oncogene|December 13, 2006
Expression of CCL9/MIP-1gamma is repressed by BCR/ABL and its restoration suppresses in vivo leukemogenesis of 32D-BCR/ABL cellsG Iotti, G Ferrari-Amorotti, C Rosafio, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 21, 1997
Activation of human B-MYB by cyclinsA Sala, M Kundu, I Casella, et al.
Leukemia|June 1, 1997
Effect of bcr-abl oligodeoxynucleotides on the clonogenic growth of chronic myelogenous leukaemia cellsP de Fabritiis, T Skorski, M S De Propris, et al.
Cell Death & Disease|June 17, 2016
Expression of μ-protocadherin is negatively regulated by the activation of the β-catenin signaling pathway in normal and cancer colorectal enterocytesL Montorsi, S Parenti, L Losi, et al.
The American Journal of Pathology|April 6, 2001
c-Myb and Bcl-x overexpression predicts poor prognosis in colorectal cancer: clinical and experimental findingsA Biroccio, B Benassi, I D'Agnano, et al.
Leukemia|October 1, 2011
c-Myb and its target Bmi1 are required for p190BCR/ABL leukemogenesis in mouse and human cellsT Waldron, M De Dominici, A R Soliera, et al.
Blood|January 15, 1998
The SH3 domain contributes to BCR/ABL-dependent leukemogenesis in vivo: role in adhesion, invasion, and homingT Skorski, M Nieborowska-Skorska, P Wlodarski, et al.
Pageof 19

Showing results (171-180 of 187) with videos related to

Sort By:
Pageof 19
Blood|July 15, 1995
Phosphatidylinositol-3 kinase activity is regulated by BCR/ABL and is required for the growth of Philadelphia chromosome-positive cellsT Skorski, P Kanakaraj, M Nieborowska-Skorska, et al.
Cancer Research|November 1, 1994
p130/pRb2 has growth suppressive properties similar to yet distinctive from those of retinoblastoma family members pRb and p107P P Claudio, C M Howard, A Baldi, et al.
Leukemia|January 1, 1994
Antisense BCR-ABL oligonucleotides induce apoptosis in the Philadelphia chromosome-positive cell line BV173T F Smetsers, T Skorski, L T van de Locht, et al.
Oncogene|December 13, 2006
Expression of CCL9/MIP-1gamma is repressed by BCR/ABL and its restoration suppresses in vivo leukemogenesis of 32D-BCR/ABL cellsG Iotti, G Ferrari-Amorotti, C Rosafio, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 21, 1997
Activation of human B-MYB by cyclinsA Sala, M Kundu, I Casella, et al.
Leukemia|June 1, 1997
Effect of bcr-abl oligodeoxynucleotides on the clonogenic growth of chronic myelogenous leukaemia cellsP de Fabritiis, T Skorski, M S De Propris, et al.
Cell Death & Disease|June 17, 2016
Expression of μ-protocadherin is negatively regulated by the activation of the β-catenin signaling pathway in normal and cancer colorectal enterocytesL Montorsi, S Parenti, L Losi, et al.
The American Journal of Pathology|April 6, 2001
c-Myb and Bcl-x overexpression predicts poor prognosis in colorectal cancer: clinical and experimental findingsA Biroccio, B Benassi, I D'Agnano, et al.
Leukemia|October 1, 2011
c-Myb and its target Bmi1 are required for p190BCR/ABL leukemogenesis in mouse and human cellsT Waldron, M De Dominici, A R Soliera, et al.
Blood|January 15, 1998
The SH3 domain contributes to BCR/ABL-dependent leukemogenesis in vivo: role in adhesion, invasion, and homingT Skorski, M Nieborowska-Skorska, P Wlodarski, et al.
Pageof 19